BOULDER, Colo., Sept. 14 /PRNewswire-FirstCall/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E.
Conway, will speak at the UBS Global Life Sciences Conference on September
27 in New York City. The public is welcome to participate in the conference
through an audio webcast on the Array BioPharma website.
Event: UBS Global Life Sciences Conference
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Wednesday, September 27, 2006
Time: 12:30 pm Eastern Time
Location: The Grand Hyatt New York, New York City
Audio Webcast: www.arraybiopharma.com
About Array BioPharma:
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule
drugs to treat life threatening and debilitating diseases. Our proprietary
drug development pipeline is focused on the treatment of cancer and
inflammatory disease and includes clinical candidates that are designed to
regulate therapeutically important targets. In addition, leading
pharmaceutical and biotechnology companies collaborate with Array to
discover and develop drug candidates across a broad range of therapeutic
areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.